Predict your next investment

HEALTHCARE | Medical Facilities & Services / Specialized Healthcare Services

See what CB Insights has to offer

Stage

Acquired | Acquired

About Professional Anesthesia Associates

Professional Anesthesia Associates provides anesthesia services at the Jackson Madison County General Hospital, West Tennessee Surgery Center, Skyline Endoscopy Center, and Physicians Surgery Center. The practice's anesthesia services include general anesthesia, orthopedic, obstetric, gynecologic, urologic, and ear, nose and throat.

Professional Anesthesia Associates Headquarter Location

131 Tucker St. Suite 5

Jackson, Tennessee, 38301,

United States

888-658-0933

Latest Professional Anesthesia Associates News

MEDNAX Announces Acquisition of Anesthesiology Practice in Tennessee

Jan 4, 2016

MEDNAX Announces Acquisition of Anesthesiology Practice in Michigan Professional Anesthesia Associates, PC, which has provided anesthesia services in the Jackson market for more than 25 years, employs 10 full-time clinicians (9 anesthesiologists and 1 anesthetist). The practice provides services at Jackson Madison County General Hospital (JMCGH), a 635-bed tertiary care center that serves a 17-county area in rural West Tennessee, and is the only tertiary care center between Memphis and Nashville. In addition, the practice provides services at the hospital’s West Tennessee Surgery Center and Skyline Endoscopy Center as well as at Physicians Surgery Center. The practice’s anesthesia services include general anesthesia, orthopedic, obstetric, gynecologic, urologic, and ear, nose and throat (ENT). “Faced with the challenges of today’s health care environment, we were looking to partner with a national medical group with an established footprint in the region and a proven track record of successful practice management,” said Todd Seabrook, M.D., who will serve as medical director for the practice. “MEDNAX provides that, as well as leadership in clinical quality initiatives, research and education that enhances our efforts to focus on data-driven solutions and value-based care that meets the needs of our partners, exceeds patient expectations and further positions our practice as an anesthesia leader in West Tennessee.” This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed. With this acquisition, 10 physician group practices became part of MEDNAX in 2015. In addition, MEDNAX completed two non-practice acquisitions. The total purchase price for the 12 acquisitions was over $850 million, consisting of closing cash and contingent consideration, MEDNAX's highest level of annual acquisition spend to date. ABOUT MEDNAX MEDNAX, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,200 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at www.mednax.com . Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission. View source version on businesswire.com: http://www.businesswire.com/news/home/20160104005231/en/ MEDNAX, Inc. Charles Lynch, 954-384-0175, x 5692 Vice President, Strategy and Investor Relations

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.